Company / SG&A per Share
FENNEC PHARMACEUTICALS INC. SG&A per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.84
FY2025
5-year range
$0.27 / $0.84
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has increased for 4 consecutive years, from $0.27 in FY2019 to $0.84 in FY2025.
Based on SEC 10-K filings.
0.84 in FY2025 with a 10-year CAGR of +13.4%.
Increased from $0.67 to $0.84 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +13.4%
Key checks
Key Insights
- FENNEC PHARMACEUTICALS INC.'s sg&a per share has grown for 4 consecutive years.
- In FY2025, sg&a per share increased 10.0% year-over-year.
- Lowest sg&a per share in the period was in FY2014.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.84 | +10.0% |
| FY2024 | $0.76 | +13.3% |
| FY2023 | $0.67 | +35.0% |
| FY2021 | $0.50 | +83.5% |
| FY2019 | $0.27 | -0.3% |
| FY2018 | $0.27 | +54.9% |
| FY2017 | $0.18 | +17.7% |
| FY2016 | $0.15 | -37.2% |
| FY2015 | $0.24 | +73.3% |
| FY2014 | $0.14 | +123.5% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026